PATENT CLAIM ANALYSIS

Application Number: 15909239
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-01
Patent Classification: ["514", "056000"]

Abstract:
The present invention provides an ophthalmic formulation consisting essentially of one or more pharmaceutically acceptable excipients; a pharmaceutically active compound that is capable of reducing the amount of inflammatory neutrophil product on the ocular surface; and optionally a second pharmaceutically active compound selected from the group consisting of a steroid, an anti-inflammatory agent, a mucolytic agent and a combination thereof. In particular, the present invention provides an ophthalmic formulation where the pharmaceutically active compound is capable of treating a clinical condition selected from the group consisting of inflammatory and immunological ocular surface disease that can cause symptoms of ocular discomfort, mucocellular aggregates/debris in tear film, symblepheron formation, fornix foreshortening, eyelid margin/conjunctival keratinization, corneal neovascularization/pannus, subconjunctival fibrosis, and herpetic eye disease. The present invention also provides a method for diagnosing or monitoring an ocular surface disease.

Claim (Index 9):
The method of  claim 8 , wherein said clinical condition comprises ocular graft-versus-host disease (oGVHD), Steven Johnson syndrome, ocular cicatricial pemphigoid (OCP), mild, moderate and severe tear deficient dry eye disease (DED), meibomian gland disease, superior limbic keratoconjunctivitis (SLK), tear sufficient DED, floppy eyelid syndrome, neurotrophic eye disease, aniridia, keratitis or a postoperative/post-trauma ocular condition.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.85185
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14362589', '13304292', '15397595', '15676968', '12685510']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7870565027887365
- 35 USC 102 Novelty (BERT): 0.5142277536439834
- Combined Prediction Score: 0.7597736278742612
- Mean Citation Score: 273.678034
- Max Citation Score: 288.3723
- Similarity Product: 200.9558473265112

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test